Determining the clinical relevance of the interaction between enzalutamide and the opioid morphine and the DOAC edoxaban to improve rational pharmacological care of patients with prostate cancer - Trial 2022-001410-20
Access comprehensive clinical trial information for 2022-001410-20 through Pure Global AI's free database. This phase not specified trial is sponsored by Radboud university medical center and is currently Ongoing. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2022-001410-20
Ongoing
Trial Details
EU Clinical Trials Register • 2022-001410-20
Determining the clinical relevance of the interaction between enzalutamide and the opioid morphine and the DOAC edoxaban to improve rational pharmacological care of patients with prostate cancer
Study Focus
Sponsor & Location
Radboud university medical center
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Primary aim is to show that there is:
ICD-10 Classifications
Malignant neoplasm of prostate
Hyperplasia of prostate
Disorder of prostate, unspecified
Other disorders of prostate
Carcinoma in situ: Prostate
Data Source
EU Clinical Trials Register
2022-001410-20
Non-Device Trial